The flashcards below were created by user Anonymous on FreezingBlue Flashcards.

  1. When did Bill 102 recieve royal assent?
    June 20, 2006 and is now known as The Transparent Drug System for Patient's Act
  2. The gov't plans to save up to $500 million per year with the reforms brought on from Bill 102, where does the gov't plan to reinvest this money?
    support improved patient access to drugs
  3. what are the key areas for patient access to drugs?
    Conditional listings - new drugs will become available on a conditional basis while it is further evaluated

    Elimination of LU mechanism - saves time filling out and tracking LU forms

    Exceptional Access - funding decisions made faster for non-listed meds

    Elimination of Section 8 coverage

    Elimination of paperwork for physician, pharmacy, and DQTC (saves valuable time for patients with life-threatening conditions or illnesses)

    faster review for breakthrough drugs by starting review process before drug is marketed

    make more drugs interchangeable with brand name drugs

    align hospital and ODB formularies for seamless patient care
  4. TDSPA ensures better value for money by:
    • lowering prices for generic drugs
    • listing more drugs in ODB thereby decreasing the cost
    • enforcing pricing commitment by manufacturers
    • setting the reimbursement price for generic drugs at 25% of brand name
    • negotiating more competitive prices for brand name drugs
    • increasing dispensing fees to better reflect true cost of dispensing
    • removing hidden rebates paid to pharmacies
  5. TDSPA promotes the appropriate use of drugs by
    • enhancing the pharmacist's role as part of the Primary Care Team
    • paying pharmacists for direct patient care
    • for services such as medication management, developing web-based best practice guidelines, assist doctors make the best prescribing choice
  6. TDSPA will create an Innovative Research Fund that will:
    investigate the value of drugs in our HCS and provide concrete evidence of better health outcomes
  7. TDSPA will strenghten transparency and accountability by:
    establishing governance of the public system

    appointing an Executive Officer who will manage the system, make decisions faster, communicate to the public, and work closely with all the stakeholders

    creating a Citizen's Council to give the public an opportunity to guide public drug policygive patients an active role in the drug listing decisions

    appointing two patient representatives to the CED
  8. what do the changes made by TDSPA mean to pharmacy?
    • a Pharmacy Council to be established that will help develop policy and reimbursement models
    • pharmacy will be protected from price increases
    • increase in fees will better reflect cost of dispensing
    • pharmacists will be paid for professional services
    • eliminate rabates from drug companies
  9. some generic drugs will be exempt from the reduced prices What are two examples?
    products older than 10 yrs

    non-solid drug products
  10. Phasing out of Professional Allowances for private sector:
    currently at 35% of brand name price

    25% by April 1, 2012

    0% by April 2, 3013
  11. On July 1, 2010 Professional Allowances completely phased out to 0% from 20% of ODB generic costs
  12. How much has the dispensing fee increased for pharmacies? (for ODB only)
    effective July 1, 2010 dispensing fee was increased by $1 for urban pharmacies (from $7 to $8), and increased up to $5 for rural pharmacies (totalling no more than $12) depending on location and distance between pharmacies.
  13. What is the cap on markup for ODB/public plan?
    no change to current markup of 8% on all drugs

    no cap is applied; however, ODB will only pay the 8%
  14. What extra funding for Professional Services are provided for pharmacies?
    $50 million in place for MedsCheck progran

    $100 million in additional funding to compensate pharmacies for professional services and to suppoer pharmacies in rural areas
  15. What are professinal allowances?
    money paid by drug companies to pharmacy owners
  16. professional services were to be reported to ODB, but audits found that all PA were not reported and were being used towards overhead costs, bonuses, and other fringe benefits.
    • pharmacists claim that without professional allowances, professional services are jeoprodized.
    • have to cut pharmacy hours, staff, services.
    • many pharmacies have closed down
  17. Who was involved in the re-selling scheme of generic drugs?
    pharmacies and wholesalers
  18. What were professional allowances used for?
    used for patient focused activities such as clinic days, compliance packaging, educational activities for staff, counselling areas, continuing education for pharmacists, pharmacy staff
  19. Transparent Drug System for Patient's Act defines:
    clear roles, responsibilities, accountabillty, and reporting requirements for all providers
Card Set:
2011-11-16 07:31:03
Study notes business test

Transparent Drug System for Patient's Act
Show Answers: